{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:41:35Z","timestamp":1791423695765,"version":"4.3.3"},"reference-count":10,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HemaSphere"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1002\/hem3.136","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T01:33:22Z","timestamp":1721871202000},"source":"Crossref","is-referenced-by-count":73,"title":["Long\u2010term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM\u20103 study"],"prefix":"10.1002","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4518-7123","authenticated-orcid":false,"given":"Michael H.","family":"Tomasson","sequence":"first","affiliation":[{"name":"Department of Internal Medicine University of Iowa  Iowa City Iowa USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Iida","sequence":"additional","affiliation":[{"name":"Department of Hematology & Oncology Nagoya City University Graduate School of Medical Sciences  Nagoya Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Niesvizky","sequence":"additional","affiliation":[{"name":"Multiple Myeloma Center New York\u2013Presbyterian Hospital\/Weill Cornell Medical Center  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[{"name":"Hematology and Cellular Therapy Department Sorbonne University, H\u00f4pital Saint\u2010Antoine and INSERM UMRS938  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar J.","family":"Bahlis","sequence":"additional","affiliation":[{"name":"Division of Hematology and Bone Marrow Transplantation, Arnie Charbonneau Cancer Institute University of Calgary  Calgary Alberta Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquin","family":"Martinez\u2010Lopez","sequence":"additional","affiliation":[{"name":"Haematology and Haemotherapy Service Hospital Universitario 12 de Octubre, Complutense University of Madrid, Centro Nacional de Investigaciones Oncol\u00f3gicas, Instituto de Investigaci\u00f3n Hospital 12 de Octubre  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenther","family":"Koehne","sequence":"additional","affiliation":[{"name":"Blood & Marrow Transplant and Hematologic Oncology Miami Cancer Institute  Miami Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5236-7785","authenticated-orcid":false,"given":"Paula","family":"Rodriguez\u2010Otero","sequence":"additional","affiliation":[{"name":"Central Unit for Clinical Trials Clinica Universidad de Navarra  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Miles Prince","sequence":"additional","affiliation":[{"name":"Cancer Immunology and Molecular Oncology Epworth Healthcare and University of Melbourne  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Viqueira","sequence":"additional","affiliation":[{"name":"Oncology Research and Development Pfizer SLU  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Leip","sequence":"additional","affiliation":[{"name":"Department of Clinical Research Pfizer Inc.  Cambridge Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Conte","sequence":"additional","affiliation":[{"name":"Oncology Research and Development Pfizer Inc.  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon T.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Global Product Development Pfizer Inc.  Cambridge Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M.","family":"Lesokhin","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology Memorial Sloan Kettering Cancer Center\/Weill Cornell Medical College  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00512"},{"key":"e_1_2_5_3_1","unstructured":"Elrexfio (elranatamab\u2010bcmm). Prescribing information. Pfizer;2023."},{"key":"e_1_2_5_4_1","unstructured":"Elrexfio (elranatamab\u2010bcmm). Summary of product characteristics. Pfizer;2023."},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02528-9"},{"key":"e_1_2_5_6_1","doi-asserted-by":"crossref","unstructured":"van deDonkN MoreauP GarfallAL et al.Long\u2010term follow\u2010up from MajesTEC\u20101 of teclistmab a B\u2010cell maturation antigen (BMCA) x CD3 bispecific antibody in patients with relapsed\/refractory multiple myeloma (RRMM). Presented at: 2023 ASCO Annual Meeting Chicago IL. Abstract 8011 June 2\u20106\u00a02023.","DOI":"10.1200\/JCO.2023.41.16_suppl.8011"},{"key":"e_1_2_5_7_1","doi-asserted-by":"crossref","unstructured":"SchinkeCD TouzeauC MinnemaMC et al. Pivotal phase 2 MonumenTAL\u20101 results of talquetamab (tal) a GPRC5DxCD3 bispecific antibody (BsAb) for relapsed\/refractory multiple myeloma (RRMM). Presented at: 2023 ASCO Annual Meeting Chicago IL. Abstract 8036 June 2\u20106 2023.","DOI":"10.1200\/JCO.2023.41.16_suppl.8036"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-159969"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01504"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2203478"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-159009"}],"container-title":["HemaSphere"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hem3.136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T17:10:14Z","timestamp":1763658614000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hem3.136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1002\/hem3.136"],"URL":"https:\/\/doi.org\/10.1002\/hem3.136","archive":["Portico"],"relation":{},"ISSN":["2572-9241","2572-9241"],"issn-type":[{"value":"2572-9241","type":"print"},{"value":"2572-9241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]},"article-number":"e136"}}